1. Concurrent nivolumab and external beam radiation therapy for hepatocellular carcinoma with macrovascular invasion: A phase 2 study. JHEP Reports 2023, December online
2. Proton beam radiotherapy vs. radiofrequency ablation for recurrent hepatocellular carcinoma: A randomized phase III trial. J Hepatol 2021;74:603-612
3. Sorafenib with or without concurrent transarterial chemoembolization in patients with advanced hepatocellular carcinoma: The phase III STAH trial. J Hepatol 2019;70:684-691
4. 2022 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma. Clin Mol Hepatol 2022 Oct;28(4):583-705
5. Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study. Liver Int 2015;35:2155-2166
6. A prospective evaluation of F-18-FDG and C-11-acetate PET/CT for detection of primary and metastatic hepatocellular carcinoma. J Nuclear Med 2008; 49:1912-1921